TrialClinIQ
PrivateLast Round
Pre Seed
Apr 28, 2026
Total Funding Raised
$150,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
TrialClinIQ operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Pre Seed round in April 2026.
TrialClinIQ is a health tech company that provides an AI-powered clinical trial recruitment platform to connect community health centers with clinical research.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, EHR & EMR, Medical AI, Patient Engagement, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TrialClinIQ Comparables
Compare TrialClinIQ with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kitsa | 84% | |
| Dyania Health | 78% | |
| Tempus | 76% |
For institutional investors. Book with your work email.
TrialClinIQ Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
TrialClinIQ Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Caduceus Capital Partners | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2026
$150K round led by Caduceus Capital Partners
For institutional investors. Book with your work email.
TrialClinIQ Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TrialClinIQ's valuation, stock price, and market status.
Is TrialClinIQ a public or private company?
TrialClinIQ is a private company.
What is the current stock price of TrialClinIQ?
TrialClinIQ is a private company, so its shares have no public market price. Caplight tracks TrialClinIQ's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TrialClinIQ worth (valuation)?
Valuation information for TrialClinIQ is not publicly available.
Can I buy TrialClinIQ stock?
TrialClinIQ shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TrialClinIQ's last funding round?
TrialClinIQ's most recent funding round was Pre Seed on April 28, 2026.
Who are the main investors in TrialClinIQ?
Key investors in TrialClinIQ include Caduceus Capital Partners.
Will TrialClinIQ IPO soon?
No public IPO plans have been announced for TrialClinIQ.
How can I track TrialClinIQ secondary market activity?
Caplight tracks bids, offers, and trades in TrialClinIQ's shares on secondary markets.